10 McKesson finance directors
At McKesson, these finance directors hold six senior director and four director titles, with current work in FP&A, strategic and transformation finance, CoverMyMeds operations, returns and reverse logistics, finance technology, and oncology and specialty finance. All ten hold McKesson roles today, useful for a finance team setting up business-unit FP&A, a transformation program or finance support for a technology unit.
Professionals to explore
Christy Flack
LinkedInExperience: Sr. Director Finance, CoverMyMeds Operations · McKesson
$539 per 30-minute call
Christy Flack moved to McKesson as Sr. Director Finance, CoverMyMeds Operations in 2026, right after Sr. Director Finance Global Operations at Owens & Minor (2025–2026). Flack was also Director, Supply Chain Finance at Owens & Minor (2022–2025) and was Director, Supply Chain Strategic Sourcing (2021–2022) and Sr. Manager, Supply Chain Strategic Sourcing (2020–2021) at Gap Inc., so operations and sourcing finance questions fit here.
Is this you? Claim your profile and get paid for calls.
Colt Templin
LinkedInExperience: Director of FP&A · McKesson
$438 per 30-minute call
In the current Director of FP&A role at McKesson (since 2025), Colt Templin oversees the migration of the MPA business to Pharmacy Services & Solutions (PSaS) from CoverMyMeds. Templin's other McKesson titles are Director, Operations FP&A (2023–2024), Director, Product FP&A (2022–2023) and Director of FP&A (2019–2021), after Finance Manager at UPMC Health Plan (2018–2019).
Is this you? Claim your profile and get paid for calls.
Jonathan Kruk
LinkedInExperience: Senior Finance Director, McKesson · McKesson
$539 per 30-minute call
Jonathan Kruk is Senior Finance Director, McKesson (since 2024) and held Corporate Finance, Director of Financial Planning and Analysis (FP&A) (2021–2025). Kruk's reporting background at McKesson includes Senior Manager, External Financial Reporting (2019–2021), Senior Manager, Global Consolidations & Financial Reporting (2019) and SOX Manager, Risk Control Group at McKesson Europe AG (2016–2019).
Is this you? Claim your profile and get paid for calls.
Katie Comeaux
LinkedInExperience: Senior Director, Transformation Finance · McKesson
$539 per 30-minute call
Katie Comeaux holds Senior Director, Transformation Finance at McKesson, a title held since 2025, after Director, Corporate FP&A (2020–2025). At American Airlines, Comeaux was Director, Corporate Development (2020) and Senior Manager, Financial Planning - Capital (2019–2020), which suits questions on corporate FP&A and on funding transformation programs.
Is this you? Claim your profile and get paid for calls.
Lindsay Holmes
LinkedInExperience: Director, Strategic Finance · McKesson
$438 per 30-minute call
Director, Strategic Finance at McKesson since 2026, Lindsay Holmes has spent the years since 2018 at McKesson as Senior Financial Analyst (2018–2021), Finance Manager (2021–2023) and Senior Finance Manager, Operations (2023–2026). That path suits questions on operations finance and strategic finance at McKesson.
Is this you? Claim your profile and get paid for calls.
Maria Price
LinkedInExperience: Senior Director, Oncology & Specialty Finance · McKesson
$539 per 30-minute call
Maria Price has been Senior Director, Oncology & Specialty Finance at McKesson since 2024, after Senior Director, Finance at Ontada (2020–2024). Price's other McKesson titles are Senior Director, McKesson Data, Evidence, and Insights (2016–2021), Finance Director, McKesson Patient Access and Adherence (2007–2016) and Sr. Manager Sales Operations & Enablement, McKesson Specialty (2005–2007), suiting specialty and oncology finance questions.
Is this you? Claim your profile and get paid for calls.
Nigel Dowling FCMA CIMA
LinkedInExperience: Senior Director Finance Technology Solutions · McKesson
$539 per 30-minute call
From Ireland, Nigel Dowling FCMA CIMA has been Senior Director Finance Technology Solutions at McKesson since 2026. Earlier titles include Senior Director Finance - Global Procurement & External Supply at Zoetis (2024–2025), Senior Director Global Supply Chain Finance, ERP SAP & Cost Accounting at Endo Pharmaceuticals (2021–2023) and Senior Director International Operations Finance at Perrigo Company plc (2016–2021), useful for ERP and cost accounting questions.
Is this you? Claim your profile and get paid for calls.
Sahag Pailian
LinkedInExperience: Sr. Director, Finance · McKesson
$539 per 30-minute call
Sahag Pailian has been Sr. Director, Finance at McKesson (CoverMyMeds) since 2026, after Director, FP&A at McKesson (2025–2026). Pailian was Director, Financial Planning & Analysis at Lupin Pharmaceuticals (2023–2025), and at Hikma Pharmaceuticals held Sr. Finance Manager - US Injectables (2020–2023) and Finance & Business Controller - Global Injectables (2018–2020), a fit for FP&A questions drawing on Lupin, Hikma and McKesson.
Is this you? Claim your profile and get paid for calls.
Tom Kilishek
LinkedInExperience: Director of Finance - Returns & Reverse Logistics · McKesson
$404 per 30-minute call
Tom Kilishek is Director of Finance - Returns & Reverse Logistics at McKesson (since 2026). As Director of FP&A (2019–2023), Kilishek led a team of financial analysts managing the financial reserves and risks of a multi-billion dollar generic pharmaceutical portfolio, after Director of Risk Management - Generic Supplier Relations (2016–2019); Senior Finance Manager (2024–2026) is also a McKesson role.
Is this you? Claim your profile and get paid for calls.
Umair H.
LinkedInExperience: Director of FP&A · McKesson
$438 per 30-minute call
Umair H. has been Director of FP&A at McKesson since 2025, after Director, Health Systems (2022–2025). Pricing roles make up the rest of Umair H.'s McKesson record: Sr. Manager, Pricing & Business Strategy (2018–2022), Pricing Manager, Gx Sell Side (2016–2018) and Sr. Pricing Analyst (2014–2016), a fit for questions on linking pricing to the financial plan.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Business-unit planning questions fit the current FP&A directors, Umair H. and Colt Templin, or Jonathan Kruk, who held an FP&A director title (2021–2025), while Katie Comeaux covers transformation finance. Christy Flack and Nigel Dowling bring supply chain and procurement finance from other companies, Tom Kilishek covers returns and generic supplier risk, Maria Price covers oncology and specialty finance, and Sahag Pailian and Lindsay Holmes suit strategic finance questions.
Questions to take into the conversation
- 01How should FP&A be organized when a company has distribution, technology and specialty businesses with very different margins?
- 02What does a finance team need to track for returns and reverse logistics in pharmaceutical distribution?
- 03How do you run finance through a business migration from one unit to another without losing reporting continuity?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.